Showing results (171-180 of 179) with videos related to
Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 179 results.
Science Advances|December 16, 2022
In vivo characterization of glutamine metabolism identifies therapeutic targets in clear cell renal cell carcinomaAkash K Kaushik, Amy Tarangelo, Lindsey K Boroughs, et al.Nature|September 6, 2016
Targeting renal cell carcinoma with a HIF-2 antagonistWenfang Chen, Haley Hill, Alana Christie, et al.European Urology|January 24, 2025
A Call for a Neoadjuvant Kidney Cancer Consortium: Lessons Learned from Other Cancer TypesAxel Bex, Michael Jewett, Bryan Lewis, et al.Cancer|August 3, 2021
Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statementGennady Bratslavsky, Neil Mendhiratta, Michael Daneshvar, et al.Nature Genetics|November 18, 2014
Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypesSteffen Durinck, Eric W Stawiski, Andrea Pavía-Jiménez, et al.Science Translational Medicine|April 1, 2026
Uncovering BAP1 deubiquitination landscape enhances mechanism elucidation and therapeutic precision for BAP1-deficient pancancersJing Han Hong, Chern Han Yong, Hong Lee Heng, et al.CA: a Cancer Journal for Clinicians|June 16, 2022
An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinomaElshad Hasanov, Debra Nana Yeboa, Mathew D Tucker, et al.Medrxiv : the Preprint Server for Health Sciences|August 20, 2025
Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapyJoan Miguel Romero, Jamie Magrill, Nikita Kalashnikov, et al.Cancer Treatment Reviews|July 24, 2026
Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapyJoan Miguel Romero, Jamie Magrill, Nikita Kalashnikov, et al.Pageof 18